Biogen (BIIB) Enterprise Value (2009 - 2026)
Biogen (BIIB) recorded Enterprise Value of $32.09 billion in Q3 2026, up 93.4% from $16.59 billion a year earlier and up 4.7% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Enterprise Value (2009 - 2026) Analysis & Trends
On a TTM basis, Biogen's Enterprise Value came in at $22.7 billion as of Sep 30, 2026, up 156.3% year-over-year; for FY2025, it came in at $22.02 billion, up 10.5% from FY2024.
- Annual Enterprise Value has a five-year compound annual growth rate of -8.7% (FY2020 to FY2025).
- Across earlier years, Enterprise Value came in at $19.92 billion in FY2024 (-45.3%), $36.45 billion in FY2023 (+4.2%), $34.97 billion in FY2022 (+10.9%) and $31.53 billion in FY2021 (-9.1%).
- The Q3 2026 figure is the highest quarterly Enterprise Value since Q4 2023.
- On a year-over-year basis, Enterprise Value has increased for four consecutive quarters, with growth averaging 6.8% over the last eight quarters.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 95.7% in Q2 2026, against a decline of 50.9% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $30.64 billion (Q2 2026), $22.78 billion (Q1 2026) and $22.02 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 32.09 Bn |
| Jun 30, 2026 | 30.64 Bn |
| Mar 31, 2026 | 22.78 Bn |
| Dec 31, 2025 | 22.02 Bn |
| Sep 30, 2025 | 16.59 Bn |
| Jun 30, 2025 | 15.65 Bn |
| Mar 31, 2025 | 17.45 Bn |
| Dec 31, 2024 | 19.92 Bn |
| Sep 30, 2024 | 26.55 Bn |
| Jun 30, 2024 | 31.86 Bn |
| Mar 31, 2024 | 30.32 Bn |
| Dec 31, 2023 | 36.45 Bn |
| Sep 30, 2023 | 34.95 Bn |
| Jun 30, 2023 | 35.17 Bn |
| Mar 31, 2023 | 35.19 Bn |
| Dec 31, 2022 | 34.97 Bn |
| Sep 30, 2022 | 33.53 Bn |
| Jun 30, 2022 | 24.79 Bn |
| Mar 31, 2022 | 27.07 Bn |
| Dec 31, 2021 | 31.53 Bn |
API Access
Biogen Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();